Status:
COMPLETED
The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Arrhythmogenic Right Ventricular Cardiomyopathy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80 lead ECG may increase the specificity and sensitivity in diagnosing this potentially life threatening inherite...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of arrhythmogenic right ventricular cardiomyopathy who are being followed up in the cardiology clinic
Exclusion
- Inability to consent
- Pacing dependent patients
- Other concomitant cardiag disease e.g. coronary artery disease
- Atrial fibrillation
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02291393
Start Date
August 1 2012
End Date
October 1 2012
Last Update
May 19 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.